Everest Clinical Research Welcomes Amy Nguyen as Chief Commercial Officer to Drive Continued Global Growth

TORONTO, December 17, 2025 — Everest Clinical Research, a global, full-service CRO, announces the appointment of Amy Nguyen as the company’s first Chief Commercial Officer (CCO). In this new role, Nguyen will build upon Everest’s commercial operations while driving sales and pipeline planning to support the company’s growing client base from the earliest stages of partnership.

Nguyen’s appointment marks the latest expansion of Everest’s executive leadership team. Earlier this year, the company welcomed Chief Operating Officer Rob Woolson, announced the promotion of Jin Dai to Chief Executive Officer, and named Irene Zhang as Founder and Executive Chairman. These leadership additions reflect Everest’s strong growth performance and the increasing global demand for its biometrics and full-service clinical solutions, despite CRO industry growth challenges.

As CCO, Nguyen will be responsible for amplifying the company’s strong presence in biometrics and continuing to grow its full-service solutions across key therapeutic areas, while ensuring clients receive flexible, innovative, and high-quality services from early engagement through project delivery.

“Amy brings incredible energy, expertise, and a hands-on leadership style to Everest. She embodies the creativity and can-do spirit that perfectly reflects Everest’s culture and what has driven our success over the years,” said Jin Dai, Everest’s CEO. “We are experiencing robust growth and increasing demand for Everest’s biometrics and full-service offerings and global project teams. Amy’s leadership will be instrumental in shaping flexible, client-centric solutions and strengthening the commercial foundation that supports our next phase of expansion.”

With more than 20 years of experience in business development across CROs, life sciences organizations, and global partnerships, Nguyen brings a proven track record of driving multimillion-dollar growth, building high-performing teams, and executing go-to-market strategies for complex service models. Nguyen most recently served as Vice President of Global Business Development and Client Management at CTI Clinical Trials and Consulting, where she led global sales operations across North America, Europe, Latin America, and the Middle East. Her career includes senior leadership roles at Catalyst Clinical Research, GreenLight Clinical, and InnoPharma International, where she consistently delivered strong revenue performance, established strategic account frameworks, and expanded market presence worldwide.